The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $513,189 in first-year total cost, median $256,595.
Most frequent study sections
- Special Emphasis Panel[ZRG1 EMNR-A (55)]2
Most frequent institutions
- INHERENT BIOSCIENCES, INC.1
- OPTIVA FERTILITY, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | AI-enhanced metabolic imaging: a non-invasive and precise IVF assessment tool1R44HD108813-01 | SANCHEZ, TIMOTHY | OPTIVA FERTILITY, INC., MA | $257,945 | ZRG1 |
| 2022 | Clinical epigenetic diagnostic for spermatogenic failure and future health risks1R43HD108826-01 | BROGAARD, KRISTIN R | INHERENT BIOSCIENCES, INC., UT | $255,244 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.